Stories

We’re proud to be part of The Liver Meeting 2025 hosted by the American Association for the Study of Liver Disease (AASLD), where leading healthcare professionals, scientists and the patient community come together to discuss the latest advances in scientific and medical innovations and care, across

Liver disease has emerged as a critical focus for the healthcare science community, driven by significant unmet needs—particularly in rare and underserved conditions.

Every person’s experience living with neuroendocrine tumors (NETs) is unique and for Melanie, coming to terms with a diagnosis of lung NETs is an ongoing journey, building knowledge and understanding of how to live with this complex and often unknown form of cancer.

Ipsen’s financial results for the first nine months of 2025 were published on 22 October 2025.